4//SEC Filing
ODINK DEBRA 4
Accession 0001214659-13-000082
CIK 0001316175other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 9:18 PM ET
Size
5.9 KB
Accession
0001214659-13-000082
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Tax Payment
Common Stock
2013-01-03$0.69/sh−3,409$2,352→ 31,812 total
Holdings
- 95,928(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Shares forfeited in lieu of payment of tax liability in connection with the vesting of 7,418 performance shares, which represent the portion of the Reporting Person's 2011 performance share award (made pursuant to the 2010 Stock Option and Incentive Plan )
- [F2]The number of shares forfeited by the Reporting Person was based on the closing price of the Issuer's common stock on January 3, 2013, the vesting date of the 2012 Grant
- [F3]Includes 10,000 shares acquired under the Issuer 2010 Employee Stock Purchase Plan on December 31, 2012.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001281719
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 9:18 PM ET
- Size
- 5.9 KB